
5.32 Delayed Data As of Sep 29 | ![]() Today’s Change | 4.26 Today|||52-Week Range 8.60 | -12.79% Year-to-Date |
The 1 analysts offering 12-month price forecasts for ImmuCell Corp have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +163.16% increase from the last price of 5.32.
The current consensus among 1 polled investment analysts is to Buy stock in ImmuCell Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.